Publication Name	World Journal of Gastroenterology
Manuscript ID	8493
Country	Italy

Received	2013-12-29 14:40
Peer-Review Started	2013-12-29 15:32
First Decision by Editorial Office Director
Return for Revision	2014-03-13 18:47
Revised	2014-04-29 02:03
Publication Fee Transferred
Second Decision by Editor	2014-07-16 12:53
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2014-07-16 13:04
Articles in Press	2014-07-16 17:53
Edit the Manuscript by Language Editor	2014-08-05 05:34
Typeset the Manuscript	2014-10-27 15:12
Publish the Manuscript Online	2014-11-17 15:12

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease
Manuscript Source	Invited Manuscript
All Author List	Giulia Paolella, Claudia Mandato, Luca Pierri, Marco Poeta, Martina Di Stasi and Pietro Vajro
Funding Agency and Grant Number	Funding Agency Grant Number FARB-ex 60% 2012 of the University of Salerno (in part) to Vajro P
Corresponding Author	Pietro Vajro, Professor, Chair of Pediatrics, Department of Medicine and Surgery, University of Salerno, via Allende, 84081 Baronissi (Salerno), Italy. pvajro@unisa.it
Key Words	Probiotics; Gut-liver axis; Intestinal microbiota; Barrier function; Small intestinal bacterial overgrowth; Bacterial translocation; Non-alcoholic fatty liver disease
Core Tip	Modulation of gut microbiota by probiotics is supported by a number of studies conducted with non-alcoholic fatty liver disease animal models and in several pilot pediatric and adult human studies. Globally, this approach appears to be a promising add-on therapeutic tool to be used in the context of a tailored multi-target therapy especially in cases where standard dietary and lifestyle changes have failed.
Publish Date	2014-11-17 15:12
Citation	Paolella G, Mandato C, Pierri L, Poeta M, Di Stasi M, Vajro P. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(42): 15518-15531
URL	http://www.wjgnet.com/1007-9327/full/v20/i42/15518.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i42.15518

Full Article (PDF)	WJG-20-15518.pdf
Full Article (Word)	WJG-20-15518.doc
Manuscript File	8493-Review.docx
Answering Reviewers	8493-Answering reviewers.pdf
Copyright License Agreement	8493-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	8493-Language certificate.pdf
Peer-review Report	8493-Peer reviews.pdf
Scientific Misconduct Check	8493-CrossCheck.jpg
Scientific Editor Work List	8493-Scientific editor work list.pdf